Pfizer Ethical Issues
Introduction
The pharmaceutical business is regularly condemned an exceptionally profit driven industry (LaMattina 2013). In this assignment I will be looking at the ethical breaches that Pfizer, a pharmaceutical company, is infamous of.
SECTION A - GENERAL
1. Ethical issues facing pharmaceutical industry
According to MacDonald (2016) the following are the ethical issues facing the pharmaceutical industry.
• Pricing
• Interference with the logical production process
• Interference with the clinical trials process.
• Use of imposter consumer backing gatherings to influence policymakers
• Making swelled claims about the viability of their products.
2. New clinical trials and medication regulatory body in South Africa
To the extent the control
…show more content…
An absence of rivalry takes into account producers to set high costs. The second reason is uneven arranging power which is caused by the absence of standard arranging power that exist in the countries with national healthcare survey frameworks (Nelson & Vega 2016).
3.2 Kant’s Deontological theory
An alternative formulation for Kant’s categorical imperative theory is respect for person. According to this formulation people should never use other people as a stepping stone to achieve their goal (Kretzchmar. Prinsloo, Prozesky, Rossouw, Sander, Siebrits & Woermann 2012:78).
Pfizer lied by delivering a fake letter of endorsement and was cruel to the Nigerians since it did not advise the general population of what was really happening. The organization was deceitful to the United States too in light of the fact that the nation was clueless about what occurred until the point when long after the medication testing was done. Overall, the scandal is unethical in terms of Kantianism (Klag 2013).
3.3 Perfect
…show more content…
Background of Pfizer
Pfizer Inc. is the biggest research-based medication creator on the planet. The organization was built up in 1849 when Charles Pfizer, a scientific expert, and Charles Erhart a confectioner, started an association in Brooklyn to fabricate mass substance chemicals, and the organization was called Charles Pfizer and Company. In 1900 the organization was incorporated in New Jersey as Charles Pfizer and Company Inc. (Llamas S.a). The company operates in three business fragments: healthcare, animal wellbeing, and consumer healthcare. Pfizer is the organisation behind well-known consumer items such as Listerine, Rolaids, Sudafed, and Visine, however the organisation’s most noteworthy income makers are its professionally prescribed medications. Pfizer 's marquee pharmaceuticals include Viagra, a treatment for erectile brokenness, Zoloft, an antidepressant, and Lipitor, a cholesterol-lowering pharmaceutical that is the top rated medicine on the planet, and the organisation’s products are showcased in more than 150 nations (Llamas S.a).
1.1 Explain what happened and what Pfizer was accused
Compound 17392
691 Words | 3 PagesA new oral pharmaceutical drug for type- two diabetes had been approved for clinical use, it was called Compound 17392. Marketing companies instantly wanted to have prescribers adopt and sell the product and researchers wanted to further investigate previous reports of liver toxicity in patients. Now since paying patients to try new pharmaceutical drugs was an issue due to it appearing to interfere with clinical judgement and upholding the duty to do what is best for the patient, a new idea of furthering research for the drug came into play. The idea included recruiting a group of physicians who were in the top ten percent of prescribers for type-two diabetes. Following regulations put in place by researchers, these physicians were to enter eligible patients into the trial for Compound
Nurofen Specific Pain Case
563 Words | 3 PagesThis situation creates an identity of the company as being fake and acting against the community. The company is going against the theory of Utilitarianism which is concerned with making decisions that promote human welfare. The Company’s bad consequences were more than good consequences making it an unethical decision which resulted in a fine of $7 million. The company was charging more price for the specific range which contained the same active ingredient breaching the theory of justice and fairness which supports the idea of fairest overall distribution of
Meat Labeling Industry In Upton Sinclair's The Jungle
1028 Words | 5 PagesMany believe that the FDA has financial reasons for allowing a drug to be on the market. In 2006, a study found that” in 22% of advisory board meetings, more than half the members had direct financial in the companies whose medial products they evaluated or their rivals”. The FDA’s advisory boards should not be able to vote on companies that they have financial ties to. The FDA says they do the best they can to create an unbiased board, but it is difficult to find “top medical experts with no ties” to pharmaceutical companies. Since a number of people have complained about this, Congress decided to make the FDA cut twenty-five percent of the advisory board that has financial ties with the pharmaceutical company being evaluated over the next five years.
Ethical Issues In Managed Care
421 Words | 2 PagesToday's health care system is difficult to understand. It has undergone dramatic changes over the years. There are many changes that shift the movement from "an indemnity plan to a managed care system. " Not only has the U.S. health care system undergone dramatic changes, but as well continues to evolve to a rapid pace (Conklin, 2002).
Austin As A Lobbyist Essay
1177 Words | 5 PagesA look at how one man and his backing help keep an entire pharmaceutical company in the position of running a monopoly. This man is named
NMC Code Of Care: A Case Study
112 Words | 1 PagesCovert use of medication can be seen as dishonest as the NMC code (2015) states respect the level to which people receiving care want to be involved in decisions about their own health, wellbeing and care; the code of practice also states act with honesty and integrity at all times, treating people fairly. In contrast however, Beauchamp and Childress (2009) highlights non disclosure, limited discolour, deception or lying may be considered when veracity and the principle of autonomy is thought to conflict with other ethical obligation. Jean was given the opportunity to understand and evaluate what was being asked and was provided with all relevant information to support their decision making process.
Marcia Angell's Argument Summary
646 Words | 3 PagesLikewise, the best treatment should not refer to local treatment standards, but the best standards available to maximize the beneficence and justice applied to participants already undertaking the burden of participating in a clinical trial. Unfortunately, ethical principles can sometimes be neglected due to competition in the field and the increase of regulations. This has resulted in some ethically questionable trials based in third world countries that violate justice, autonomy, and beneficence to obtain faster results. Harold Varmus and David Satcher’s perspective on what standards and guidelines should be implemented in clinical trials in third world countries differs from that of Angell’s arguments. They make the argument that compared to other approaches, a placebo is the most justified way to obtain clear and rapid results from clinical trials regardless of what treatments may currently be available.
Deontology Vs Utilitarianism
1515 Words | 7 PagesDecisions about right and wrong fill each and every day. Turmoil exists due to deciding if Deontology, where one acts based on the right motives, or if Utilitarianism, where one should act in a way that would produce the best results and consequences, should govern decisions and their morality. However, I believe Deontology, which is reason and duty based, serves as the superior way to dictate morality. In this paper, I will explain both the principles of Deontology and Utilitarianism, discuss the superior aspects of Deontology as compared to Utilitarianism, as well as grapple with objections to Deontology. While both ethical frameworks contain parts of ideologies that could be seen as valid, Kant’s theory on Deontology holistically remains
Arguments Against Big Pharma
1087 Words | 5 PagesEvery citizen in the United States has individual rights protected by the Constitution. This protection also includes businesses that have gone through the legal process to become a legal entity ; more commonly known as becoming a corporation. Many times these individual rights, protected by the Constitution, conflict with the common good and as history shows, the courts consistently side with the common good when faced with a case that pits these two against each other. Big Pharma are corporations exercising their individual rights to market, and sell their product to consumers. In the process, the common good is suffering.
Facebook Big Brother Likes Us Case Analysis
1150 Words | 5 Pages4. Comment on each of the ethical issues mentioned in this case. Rank them
Medical Office Procedures Research Paper
440 Words | 2 PagesAAS- Medical Office Procedures Week 2 Discussion Judy Potts Explain why pharmaceutical representatives leave samples of expensive medications with physicians. Pharmaceutical representatives, show the physicians the newest drugs on the market, to drum up business for the pharmaceutical companies. The representatives leave samples of the products, In hopes that the doctor will strat prescribing their new name brand products for his patients instead of generic drugs. Also, in some cases, the patients are not financially able to purchase a new drug not knowing if it will help with their disease. The clinic 's management staff will determine whether they will be except the newest medication samples from the representative.
Porter's Five Forces In Healthcare
1087 Words | 5 PagesThe model of the Five Competitive Forces, developed by Michael E. Porter, is based on corporate strategy, industry structure and the way they change. Porter has identified five competitive forces that shape every industry and every market and they determine the intensity of competition and hence the profitability and attractiveness of an industry. We further look into how the strategy and industry structure is placed in the field of healthcare and hospitals and analyze the attractiveness of the overall industry. 2.2 Rivalry among competitors Industry Rivalry is one of the 5 forces used to determine the intensity of competition in the industry. Competition in health care is the potential to provide with a mechanism to reduce cost and hence accessible
Porter's Five Forces Analysis Pharmaceutical Industry
720 Words | 3 PagesPORTERS FIVE FORCES ANALYSIS - PHARMA INDUSTRY Using Porter's Five Forces we can analyse the scope of the pharmaceutical industry. It looks into five factors namely, competitive rivalry, threat of new entrants, threat of substitute products, bargaining power of suppliers and bargaining power of customers. " Competitive rivalry: The pharmaceutical industry is highly fragmented with almost 3,000 pharma companies and 10,500 manufacturing units. Due to increasing demand of high-quality drugs, low-to-moderate entry barrier to the new entrant, the presence of a number of large and small firm this market is highly competitive.
Business Ethics Case Study: The Johnson And Johnson Case
1262 Words | 6 PagesIntroduction The key ethical issues that were presented in this case study were quality control, lack of customer care, responsiveness, and harming the customer. The Johnson and Johnson case may have been seen as a turning point due to many things the company did right. However, there were many ethical issues in this case which will be explored more throughout this paper.
Rorer Converts-Poulenc Case Study
2104 Words | 9 PagesINTRODUCTION The latter decade of the 20th century brought a number of major innovations to the pharmaceutical industry, most notably a remarkable wave of successful joint ventures and mergers between big and medium players in the market. In this case study we analyzed the Rorer and Rhône-Poulenc (RP) merger in July 31, 1990 that created a major multinational company: the Rhône-Poulenc Rorer, Inc. (RPR), where the RP became the majority shareholder, owning 68 percent of the RPR’s shares. Prior to the merger, Rorer lacked the resources to access the European market, and the firm presented relatively low cash balance and rising debt which, according to financial analysts, appeared to be handicapping its strategy of growth by acquisitions.
More about Pfizer Ethical Issues
Compound 17392
691 Words | 3 PagesNurofen Specific Pain Case
563 Words | 3 PagesMeat Labeling Industry In Upton Sinclair's The Jungle
1028 Words | 5 PagesEthical Issues In Managed Care
421 Words | 2 PagesAustin As A Lobbyist Essay
1177 Words | 5 PagesNMC Code Of Care: A Case Study
112 Words | 1 PagesMarcia Angell's Argument Summary
646 Words | 3 PagesDeontology Vs Utilitarianism
1515 Words | 7 PagesArguments Against Big Pharma
1087 Words | 5 PagesFacebook Big Brother Likes Us Case Analysis
1150 Words | 5 PagesMedical Office Procedures Research Paper
440 Words | 2 PagesPorter's Five Forces In Healthcare
1087 Words | 5 PagesPorter's Five Forces Analysis Pharmaceutical Industry
720 Words | 3 PagesBusiness Ethics Case Study: The Johnson And Johnson Case
1262 Words | 6 PagesRorer Converts-Poulenc Case Study
2104 Words | 9 Pages